Heterotopic ossification in complex orthopaedic combat wounds: Quantification and characterization of osteogenic precursor cell activity in traumatized muscle

Journal of Bone and Joint Surgery

Volumn 93, Issue 12, 2011, Pages 1122-1131

  Davis, Thomas A ^a   O'Brien, Frederick P ^b   Anam, Khairul ^a   Grijalva, Steven ^b   Potter, Benjamin K ^b   Elster, Eric A ^b  

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTEGRIN; BETA1 INTEGRIN; CARTILAGE OLIGOMERIC MATRIX PROTEIN; CD31 ANTIGEN; CD34 ANTIGEN; CD37 ANTIGEN; CD45 ANTIGEN; FIBROBLAST GROWTH FACTOR RECEPTOR 2; GELATINASE B; HERMES ANTIGEN; HLA ANTIGEN; HLA DR ANTIGEN; PHOSPHATE REGULATING NEUTRAL ENDOPEPTIDASE; SCAVENGER RECEPTOR BI; TRANSCRIPTION FACTOR SOX9; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1;

ADHERENT CELL; ADULT; ARTICLE; BATTLE INJURY; CELL DIFFERENTIATION; CELL LINEAGE; CELL SUSPENSION; CLINICAL ARTICLE; COLONY FORMING CELL; CONNECTIVE TISSUE CELL; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HAMSTRING; HETEROTOPIC OSSIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INCUBATION TIME; MALE; MILITARY SERVICE; MUSCLE BIOPSY; OSTEOBLAST; PREVALENCE; PRIORITY JOURNAL; PROGENY; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TENDON GRAFT; TRAUMATIC BRAIN INJURY; WAR;

EID: 79961069198     PISSN: 00219355     EISSN: 15351386     Source Type: Journal    
DOI: 10.2106/JBJS.J.01417     Document Type: Article

References (37)

1. Tidball JG. Inflammatory processes in muscle injury and repair. Am J Physiol Regul Integr Comp Physiol. 2005;288:R345-53. (Pubitemid 40129595)
2. Kaplan FS, Glaser DL, Hebela N, Shore EM. Heterotopic ossification. J Am Acad Orthop Surg. 2004;12:116-25.
3. Pittenger DE. Heterotopic ossification. Orthop Rev. 1991;20:33-9.
4. Hoffer MM, Garrett A, Brink J, Perry J, Hale W, Nickel VL. The orthopaedic management of brain-injured children. J Bone Joint Surg Am. 1971;53:567-77.
5. Garland DE, Keenan MA. Orthopedic strategies in the management of the adult head-injured patient. Phys Ther. 1983;63:2004-9. (Pubitemid 14206345)
6. Garland DE, Razza BE, Waters RL. Forceful joint manipulation in head-injured adults with heterotopic ossification. Clin Orthop Relat Res. 1982;169:133-8. (Pubitemid 12021019)
7. Potter BK, Burns TC, Lacap AP, Granville RR, Gajewski D. Heterotopic ossification in the residual limbs of traumatic and combat-related amputees. J Am Acad Orthop Surg. 2006;14(10 Spec No.):S191-7.
8. Lindholm TS, Viljakka T, Vankka E, Popov L, Lindholm TC. Development of heterotopic ossification around the hip. A long-term follow-up of patients who underwent surgery with two different types of endoprostheses. Arch Orthop Trauma Surg. 1986;105:263-7. (Pubitemid 17066849)
9. Morrey BF, Adams RA, Cabanela ME. Comparison of heterotopic bone after anterolateral, transtrochanteric, and posterior approaches for total hip arthroplasty. Clin Orthop Relat Res. 1984;188:160-7. (Pubitemid 14029168)
10. Brooker AF, Bowerman JW, Robinson RA, Riley LH Jr. Ectopic ossification following total hip replacement. Incidence and a method of classification. J Bone Joint Surg Am. 1973;55:1629-32.
11. Forsberg JA, Pepek JM, Wagner S, Wilson K, Flint J, Andersen RC, Tadaki D, Gage FA, Stojadinovic A, Elster EA. Heterotopic ossification in high-energy wartime extremity injuries: prevalence and risk factors. J Bone Joint Surg Am. 2009;91:1084-91.
12. Hawksworth JS, Stojadinovic A, Gage FA, Tadaki DK, Perdue PW, Forsberg J, Davis TA, Dunne JR, Denobile JW, Brown TS, Elster EA. Inflammatory biomarkers in combat wound healing. Ann Surg. 2009;250:1002-7.
13. Potter BK, Burns TC, Lacap AP, Granville RR, Gajewski DA. Heterotopic ossification following traumatic and combat-related amputations. Prevalence, risk factors, and preliminary results of excision. J Bone Joint Surg Am. 2007;89:476-86. (Pubitemid 46365347)
14. Forsberg JA, Potter BK. Heterotopic ossification in wartime wounds. J Surg Orthop Adv. 2010;19:54-61.
15. Potter BK, Forsberg JA, Davis TA, Evans KN, Hawksworth JS, Tadaki D, Brown TS, Crane NJ, Burns TC, O'Brien FP, Elster EA. Heterotopic ossification following combat-related trauma. J Bone Joint Surg Am. 2010;92 Suppl 2:74-89.
16. Nesti LJ, Jackson WM, Shanti RM, Koehler SM, Aragon AB, Bailey JR, Sracic MK, Freedman BA, Giuliani JR, Tuan RS. Differentiation potential of multipotent progenitor cells derived from war-traumatized muscle tissue. J Bone Joint Surg Am. 2008;90:2390-8.
17. Jackson WM, Aragon AB, Bulken-Hoover JD, Nesti LJ, Tuan RS. Putative heterotopic ossification progenitor cells derived from traumatized muscle. J Orthop Res. 2009;27:1645-51.
18. De Bari C, Dell'Accio F, Vanlauwe J, Eyckmans J, Khan IM, Archer CW, Jones EA, McGonagle D, Mitsiadis TA, Pitzalis C, Luyten FP. Mesenchymal multipotency of adult human periosteal cells demonstrated by single-cell lineage analysis. Arthritis Rheum. 2006;54:1209-21. (Pubitemid 43672933)
19. Banfi A, Muraglia A, Dozin B, Mastrogiacomo M, Cancedda R, Quarto R. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: implications for their use in cell therapy. Exp Hematol. 2000;28:707-15. (Pubitemid 30398528)
20. Mauney JR, Kaplan DL, Volloch V. Matrix-mediated retention of osteogenic differentiation potential by human adult bone marrow stromal cells during ex vivo expansion. Biomaterials. 2004;25:3233-43. (Pubitemid 38234784)
21. Mauney JR, Kirker-Head C, Abrahamson L, Gronowicz G, Volloch V, Kaplan DL. Matrix-mediated retention of in vitro osteogenic differentiation potential and in vivo bone-forming capacity by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion. J Biomed Mater Res A. 2006;79:464-75. (Pubitemid 44845159)
22. Probst A, Spiegel HU. Cellular mechanisms of bone repair. J Invest Surg. 1997;10:77-86. (Pubitemid 27296667)
23. Neuss S, Becher E, Wöltje M, Tietze L, Jahnen-Dechent W. Functional expression of HGF and HGF receptor/c-met in adult human mesenchymal stem cells suggests a role in cell mobilization, tissue repair, and wound healing. Stem Cells. 2004;22:405-14. (Pubitemid 38736624)
24. Komori T. Regulation of skeletal development by the Runx family of transcription factors. J Cell Biochem. 2005;95:445-53. (Pubitemid 41420175)
25. Born AK, Rottmar M, Lischer S, Pleskova M, Bruinink A, Maniura-Weber K. Correlating cell architecture with osteogenesis: first steps towards live single cell monitoring. Eur Cell Mater. 2009;18:49-62.
26. Liu F, Akiyama Y, Tai S, Maruyama K, Kawaguchi Y, Muramatsu K, Yamaguchi K. Changes in the expression of CD106, osteogenic genes, and transcription factors involved in the osteogenic differentiation of human bonemarrowmesenchymal stem cells. J Bone Miner Metab. 2008;26:312-20. (Pubitemid 351950701)
27. Lee RH, Kim B, Choi I, Kim H, Choi HS, Suh K, Bae YC, Jung JS. Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem. 2004;14:311-24. (Pubitemid 39179200)
28. Aubin JE. Advances in the osteoblast lineage. Biochem Cell Biol. 1998;76:899-910. (Pubitemid 29450559)
29. Nakashima K, de Crombrugghe B. Transcriptional mechanisms in osteoblast differentiation and bone formation. Trends Genet. 2003;19:458-66. (Pubitemid 36930029)
30. Di Cesare PE, Fang C, Leslie MP, Tulli H, Perris R, Carlson CS. Expression of cartilage oligomeric matrix protein (COMP) by embryonic and adult osteoblasts. J Orthop Res. 2000;18:713-20.
31. Ortega N, Behonick DJ, Werb Z. Matrix remodeling during endochondral ossification. Trends Cell Biol. 2004;14:86-93. (Pubitemid 38186642)
32. Ortega N, Wang K, Ferrara N, Werb Z, Vu TH. Complementary interplay between matrix metalloproteinase-9, vascular endothelial growth factor and osteoclast function drives endochondral bone formation. Dis Model Mech. 2010;3:224-35.
33. Ben David D, Reznick AZ, Srouji S, Livne E. Exposure to pro-inflammatory cytokines upregulates MMP-9 synthesis by mesenchymal stem cells-derived osteoprogenitors. Histochem Cell Biol. 2008;129:589-97.
34. Mayer H, Bertram H, Lindenmaier W, Korff T, Weber H, Weich H. Vascular endothelial growth factor (VEGF-A) expression in human mesenchymal stem cells: autocrine and paracrine role on osteoblastic and endothelial differentiation. J Cell Biochem. 2005;95:827-39. (Pubitemid 41420169)
35. Teplyuk NM, Haupt LM, Ling L, Dombrowski C, Mun FK, Nathan SS, Lian JB, Stein JL, Stein GS, Cool SM, van Wijnen AJ. The osteogenic transcription factor Runx2 regulates components of the fibroblast growth factor/proteoglycan signaling axis in osteoblasts. J Cell Biochem. 2009;107:144-54.
36. Chen KD, Li YS, Kim M, Li S, Yuan S, Chien S, Shyy JY. Mechanotransduction in response to shear stress. Roles of receptor tyrosine kinases, integrins, and Shc. J Biol Chem. 1999;274:18393-400.
37. Knippenberg M, Helder MN, Doulabi BZ, Semeins CM, Wuisman PI, Klein-Nulend J. Adipose tissue-derived mesenchymal stem cells acquire bone cell-like responsiveness to fluid shear stress on osteogenic stimulation. Tissue Eng. 2005;11:1780-8. (Pubitemid 43120189)